
In this episode, Scott Becker highlights six notable companies, including Moderna, Estee Lauder, and Jeep’s parent Stellantis, that have seen significant stock declines over the past year.
Loading summary
A
This is Scott Becker with the Becker Private Equity and Business podcast. These are six stocks that have plunged over the last year in big name stocks, at least relatively big name stocks. And we're not going to tell a lot of story behind them, but this will give you six stocks that have just really had a tough last 52 weeks. First is the vaccine maker Moderna, which is down about 74% over the last year, just having a horrible time. Second is Acadia Healthcare, which keeps on seeming to get in trouble from either the government or lawyers and other types of things. They're down about 71% over the last year. Third is Stellantis Jeep. And again, my Jeep Cherokee, which I love, which is about a 21 model, recently had to have its battery replaced. But overall I love the Jeep Cherokee. It's their second best selling car of all time. The moronic CEO at Stellantis Jeep got rid of that in their line to go, you know, to diverge the line some, the Compass being the lower end vehicle, the Grand Cherokee being their higher end vehicle, but really screwed the pooch. They're down almost 63% over the last year. Estee Lauder, the makeup company. And the sad thing is one of our closest family friends works at Estee Lauder, but they're down 61% the last year. American Eagle Outfitters. And I don't know anybody that shops anymore. The bloom is off the rose at a e O down 52% over the last year. And finally, Oatley, the oat milk people. I almost feel like some days oat milk's gone through its greatest phase in the greatness of the oat milk era. Somebody's got to make oat milk great again, but always down 40 years over the last year. And again, really another example of a stock that is struggling and not where people would like it to be. But again, those are six big names. Just a couple big names. Amongst them, Moderna, American Eagle Outfitters, Jeep, Oatley, Estee Lauder, Acadia Healthcare that have just got crushed over the last year. Now, now the good news is I don't own any of these names directly and that's not because I'm some kind of genius. As we express regularly, I do own Astero Labs directly, which I think is in the top number of stocks that are down 60% this year, year to date. So even doing worse than these stocks, there's plenty of that. But. But the point is these are six stocks getting crushed. I'm not an investor in them. I don't know that you should be either, but that's for other people to decide and talk about. Thank you for listening to the Becker Private Equity and Business Podcast. Thank you very, very much.
B
So you've got a business, but what about a brand? The difference? More of you. WIX gives you the freedom to create your website, own your brand and do it on your own, exactly how you envisioned it. Experience limitless customization. Boost your creativity and efficiency with AI tools for every part of your business journey. Scale up with built in SEO, ecom and scheduling features. Put more of you in your business. Go to wix.com and do it all yourself.
Becker Private Equity & Business Podcast
Episode: 6 Big-Name Stocks That Got Crushed This Year
Host: Scott Becker
Release Date: April 26, 2025
In Episode 6 of the Becker Private Equity & Business Podcast, host Scott Becker delves into the tumultuous year faced by six prominent stocks. Focusing on significant declines, Scott provides insights into each company's struggles over the past 52 weeks, offering listeners a comprehensive overview of notable setbacks in the market.
Timestamp: [00:15]
Scott opens the discussion with Moderna, a leading vaccine manufacturer renowned for its rapid development of mRNA vaccines. Despite its groundbreaking work, Moderna has experienced a staggering 74% decline over the last year.
“First is the vaccine maker Moderna, which is down about 74% over the last year, just having a horrible time.”
— Scott Becker [00:15]
The downturn is attributed to various factors, including diminishing demand post-pandemic and increased competition in the biotech sector. Investors are grappling with uncertainties about Moderna's long-term growth prospects beyond COVID-19 vaccines.
Timestamp: [00:35]
Next, Scott discusses Acadia Healthcare, a provider in the behavioral health sector. The company has plummeted 71% in value over the past year, primarily due to ongoing legal issues and governmental scrutiny.
“Acadia Healthcare, which keeps on seeming to get in trouble from either the government or lawyers and other types of things. They're down about 71% over the last year.”
— Scott Becker [00:35]
These challenges have eroded investor confidence, highlighting the vulnerabilities of companies operating in highly regulated industries.
Timestamp: [00:55]
Stellantis Jeep is the third stock on Scott's list, with a 63% decline. Despite the beloved Jeep Cherokee being the company’s second-best-selling vehicle, recent strategic missteps by the CEO have negatively impacted the brand.
“The moronic CEO at Stellantis Jeep got rid of that in their line to go, you know, to diverge the line some... they really screwed the pooch.”
— Scott Becker [01:10]
Scott shares a personal anecdote about his Jeep Cherokee, emphasizing his satisfaction with the vehicle despite its battery issues. The CEO’s decision to streamline the product line, removing the Cherokee in favor of other models like the Compass and Grand Cherokee, has not resonated well with consumers.
Timestamp: [01:30]
Estée Lauder, a titan in the cosmetics industry, has seen its stock decline by 61%. Scott expresses a personal connection, mentioning a family friend employed at the company, which underscores the broader impact of the downturn.
“Estee Lauder, the makeup company... they're down 61% the last year.”
— Scott Becker [01:45]
The decline may be influenced by shifting consumer preferences, increased competition from indie brands, and economic factors affecting discretionary spending on beauty products.
Timestamp: [02:00]
American Eagle Outfitters (AEO) follows, with a 52% decrease in stock value. Scott attributes the slump to declining shopper engagement and possibly outdated retail strategies.
“I don't know anybody that shops anymore. The bloom is off the rose at a e O down 52% over the last year.”
— Scott Becker [02:05]
The fashion retail sector's transformation, accelerated by e-commerce growth and changing consumer behaviors, has posed substantial challenges for traditional brick-and-mortar companies like AEO.
Timestamp: [02:20]
Rounding out the list is Oatly, the oat milk company, which has struggled with a 40% decline. Scott comments on the competitive landscape of plant-based milk alternatives.
“Somebody's got to make oat milk great again, but always down 40 years over the last year.”
— Scott Becker [02:25]
Despite the oat milk trend reaching its peak, Oatly has faced difficulties maintaining its market share amid increasing competition and market saturation.
Timestamp: [02:40]
Scott reflects on his investment strategy, revealing that he does not own any of the six discussed stocks. However, he mentions holding shares in Astero Labs, another company experiencing significant losses.
“I do own Astero Labs directly, which I think is in the top number of stocks that are down 60% this year, year to date.”
— Scott Becker [02:50]
This admission serves to illustrate that even amidst downturns, there are numerous investment opportunities, albeit with their own risks.
Timestamp: [03:05]
Concluding the discussion, Scott advises caution regarding the six highlighted stocks, emphasizing that neither he nor listeners should consider investing in them without thorough analysis.
“I'm not an investor in them. I don't know that you should be either, but that's for other people to decide and talk about.”
— Scott Becker [03:10]
He underscores the importance of due diligence and strategic portfolio management in navigating volatile markets.
Scott Becker's analysis offers a sobering look at six major stocks that have underperformed in 2025. By highlighting the specific challenges each company faces, he provides valuable context for investors seeking to understand market dynamics and make informed decisions. The episode serves as a cautionary tale about the volatility inherent in both established and emerging companies across various industries.
Note: This summary excludes the advertisement segment that begins at [02:29], focusing solely on the podcast's core content as per the listener's request.